Media & Investors
Get the latest news and discover our mission and vision. Meet our company speakers and get in touch for press and investor inquiries.
Get the latest news and discover our mission and vision. Meet our company speakers and get in touch for press and investor inquiries.
Read the latest about myTomorrows
July 18, 2025
myTomorrows launches new data survey. Findings identify physician perceived value of AI in the trial access and discovery process, but more needs to be done to adoption.
July 18, 2025
New myTomorrows’ research identifies physician related challenges in the clinical trial discovery and access process, highlighting the how technology and AI can help.
July 17, 2025
myTomorrows launches new data report, based on survey of U.S. based healthcare professionals, entitled ‘Searching for solutions: How physicians navigate trial access and technology’.
June 24, 2025
Romina Dibra, Senior Site Manager at myTomorrows assesses how the discovery of reliable biomarkers for Parkinson’s marks a turning point in the fight against this condition.
May 28, 2025
Health tech company myTomorrows launches a dedicated platform to help BioPharma companies compliantly manage expanded access programs with efficiency.
May 27, 2025
Michel van Haten, MD, explores how AI is reshaping the future of clinical research and development via personalized treatment pathways and intuitive data modelling.
May 23, 2025
Michel van Harten, MD, analyses the use of AI to overcome real-world constraints in accessing clinical trials.
May 22, 2025
Michel van Harten, MD, examines how AI-powered platforms, such as myTomorrows’, can help to promote equity in patient access to trials.
May 21, 2025
Michel van Harten, MD, discusses the importance of transparency and trust in the adoption of AI in clinical trials.
May 20, 2025
myTomorrows announces a major milestone in matching over 15,000 patients to pre-approval treatments worldwide.
May 1, 2025
myTomorrows has been shortlisted for the Inclusive Patient Experience Design category of the Fierce DEI Awards, recognizing advancements in diversity, equity, and inclusion in clinical trial access and recruitment.
April 16, 2025
Scout and myTomorrows announce an exciting partnership designed to support international trial patient access.
April 15, 2025
myTomorrows and Scout partner to enhance global cross-border patient recruitment with AI-powered support and patient concierge services.
March 26, 2025
CEO Michel van Harten MD, explores how myTomorrows uses AI to improve clinical trial matching, improve patient access, and accelerate recruitment.
February 26, 2025
Clinical trial matchmaker myTomorrows has struck up a partnership with personal health recordkeeper Patients Know Best (PKB) so that UK participants can search for possible trials to join.
February 25, 2025
myTomorrows and Patients Know Best (PKB) have partnered to enable UK patients with unmet medical needs to conduct more efficient searches for further treatment options.
February 17, 2025
Romina Dibra MD, expert at healthcare technology company myTomorrows, has shared her insight into the most recent technological advancements in ALS Management and how they aim to enhance early diagnosis, significantly improve quality of life and provide more effective, personalized treatments.
February 14, 2025
Angela Sarmiento Betancourt, MD. at myTomorrows, shares her insights into current strategies and patient-centric research advancements for the treatment of type 1 diabetes.
February 7, 2025
With the goal of streamlining industry-wide clinical trial recruitment and improving patient outcomes, myTomorrows unveils its next major AI-powered technological advancement.
February 7, 2025
Michel van Harten, MD, discusses the importance of accessibility within oncological clinical trials which pave the way for better patient outcomes and accelerate critical cancer treatments.
February 6, 2025
Designed to streamline clinical trial recruitment, the platform supercharges how physicians search, pre-screen, and refer patients — helping trial sponsors accelerate enrollment, enhance diversity, and optimize operations.
February 3, 2025
Michel van Harten, MD, discusses how physicians and BioPharma companies and patient advocacy groups can address trust challenges by actively engaging with patient communities to empower them to participate in shaping the future of medicine.
February 3, 2025
Danny den Hamer, myTomorrows Product Manager discussed the use of AI to improve oncology care and how it can support finding the right clinical trials for patients.
January 20, 2025
Angela Sarmiento Betancourt MD, Medical Affairs Manager shares her insights on the key red flags of cervical cancer, including some common symptoms and how to spot them early.
January 15, 2025
Michel van Harten, MD, discusses how by addressing structural barriers and expanding awareness can help boost participation in clinical trials, potentially advance the development and approval of new drugs, and inform accessibility for patients with rare diseases.
January 13, 2025
Michel van Harten, MD, contributes to the discussion noting the emerging importance of decentralized trial designs, enhanced community engagement and the important role of patient advocacy groups.
January 3, 2025
In this discussion, Jytte van Huijstee, Director of Clinical Trial Operations at myTomorrows, shares insights on technology’s role in clinical trials, addressing recruitment gaps, and fostering diversity.
December 17, 2024
The myTomorrows search function now includes the ISRCTN while its platform has added AI eligibility checking for clinical trials.
December 5, 2024
Drawing on its extensive experience connecting physicians and patients to different treatment options, myTomorrows will address challenges in accessing treatments in development across the growing and diverse APAC market.
December 4, 2024
The primary goal of the hub is to build an operational foundation that can serve growing markets in the region and help patients.
November 27, 2024
In this podcast Michel van Harten, MD speaks about creating better information systems for physicians and patients & how shared decision-making can improve drug development and more.
October 24, 2024
In this article, Michel van Harten MD, discusses the profound consequences that equitable and ethical care can have on patient outcomes.
September 30, 2024
Kelly Brazzo, founder and CEO of CureLGMD2i Foundation, and Dennis Akkaya, chief Commercial Officer at MyTomorrows, share insights on a new partnership that aims to ease accessibility to drug development trials for patients with LGMD.
September 25, 2024
myTomorrows CEO Michel van Harten, MD, discusses how Infusing DEI considerations into clinical trial recruitment and enrollment will prove crucial for drug discovery and novel therapies.
September 9, 2024
CEO of myTomorrows, Michel van Harten M.D. discusses the dangerous implications of medical misinformation, not only for patients but also for healthcare professionals and the wider BioPharma industry.
September 4, 2024
Under a new partnership, CureLGMD2i will leverage myTomorrows' extensive search engine of ongoing clinical trials to provide patients, caregivers, and healthcare professionals with up-to-date, accessible information about pre-approval treatments that may be relevant to them.
September 3, 2024
Global health technology company myTomorrows announce a new partnership with Pancreatic Cancer Europe (PCE), a multi-stakeholder platform dedicated to improving care for pancreatic cancer patients.
August 27, 2024
Pancreatic cancer is notoriously challenging to treat, with a life expectancy of only 6-12 months at the time of diagnosis and a 5-year survival rate of just 10%. This partnership aims to enhance access to clinical trials for people suffering with pancreatic cancer by leveraging myTomorrows’ extensive search engine of ongoing trials.
July 1, 2024
Marshall Van Beurden, joins myTomorrows as Chief Technology Officer.. Van Beurden previously was the Managing Director for the Amazon Web Services (AWS) development center in the Netherlands and led the Enterprise Engineering team at Miro.
June 10, 2024
The US FDA recently announced a new initiative aimed at improving access to cancer trials among traditionally underserved populations. myTomorrows CEO Michel van Harten talked to Medtech Insight about how the agency’s plan might reshape the landscape of clinical trials going forward.
May 16, 2024
Jytte van Huijstee, Director of Clinical Trial Operations at myTomorrows, highlights the shift towards more patient-centric clinical trials. This approach focuses on designing trials that are more considerate of the patient’s needs and convenience, which can enhance patient recruitment and retention.
April 9, 2024
A new collaboration announced today will help provide brain tumour patients and physicians with accurate information about clinical trials in a bid to improve patient access.
April 9, 2024
Affecting 80,000 people in England, 12% of brain tumour patients survive beyond five years of diagnosis. myTomorrows has announced a new partnership with a UK-based charity, brainstrust, to support individuals living with brain cancer.
April 5, 2024
Affecting 80,000 people in England, 12% of brain tumour patients survive beyond five years of diagnosis. myTomorrows has announced a new partnership with a UK-based charity, brainstrust, to support individuals living with brain cancer.
April 4, 2024
myTomorrows and UK brainstrust plans to increase patient recruitment in brain tumour clinical trials by increasing awareness.
April 4, 2024
myTomorrows, a global health technology company connecting patients with all possible treatment options, today announced a new partnership with brainstrust, a UK-based charity that helps people living with a brain tumor reach their potential and thrive.
April 1, 2024
Certain features, commonplace on most e-commerce platforms, can help transform clinical trial search databases.
March 15, 2024
A non-profit organisation representing the amyotrophic lateral sclerosis (ALS) community in the US is taking a digital approach to connecting patients with suitable clinical trials.
March 14, 2024
Partnership with leading US-based ALS patient advocacy group furthers myTomorrows' mission of ensuring that patients confronting life-threatening diseases are aware of all possible treatment options
December 6, 2023
CEO Michel van Harten speaks with Clinical Trial Vanguard about myTomorrows’ innovative use of AI in physician-led clinical trial screening.
November 29, 2023
"I started myTomorrows in 2012 after losing my father to an aggressive form of lung cancer. As a physician and founder of several biotech companies, I thought I could help him find and access a treatment in development. But I was surprised at how complicated and slow the process was. I decided this had to change, so I dedicated myself to creating an easier and faster way for patients to access treatments in development.
We have grown a lot since then, and our team of experts has helped patients in over 60 countries. But our guiding principle remains the same: We believe every patient should have access to all possible treatment options. We are here for you, so let us know how we can help."
September 13, 2023
myTomorrows teams up with digital health innovator Congenica, highlighting tech’s role in the future of healthcare.
July 25, 2023
myTomorrows shares insights on discovering clinical trials for cancer.
June 28, 2023
myTomorrows’ CEO explores the power of AI for matching patients with the clinical trials right for them
April 27, 2023
Fierce Biotech shares launch of myTomorrows exciting new AI-backed patient pre-screening tool.
April 26, 2023
The global Health technology company myTomorrows said it launched the beta version of TrialSearch AI, a first-of-its-kind artificial intelligence tool to broaden physician insights into clinical trials and expanded access programs in the myTomorrows’ curated database.
Our experts have been pulled in to discuss a wide range of topics, from patient-centricity, clinical trials, expanded access, innovation, healthcare technology, artificial intelligence, and many more. Get in touch with them.
myTomorrows aims to break barriers for eligible patients seeking information about clinical trials and we support referrals to trial sites. When patients are not eligible to clinical studies, we can help them and their physicians to further explore and navigate the complexities of expanded access programs.
Our digital platform connects all stakeholders in pre-approval access and supports both clinical trial and expanded access workflows.
myTomorrows operates globally and has offices in Amsterdam and New York City.
We’ve helped
A community of
Trusted by
Media inquiries
mytomorrows@headline.media
